NSE · DCAL
Dishman Carbogen Amcis Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,096
of 5,072 stocks
▼ 71W
Peak #1,089 · 21 Sep 2026
Dishman Carbogen Amcis Limited is a smallcap company in the Healthcare space and has a subdued return on equity, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
2,637.22 Cr
P/E Ratio
27.04
P/B Ratio
0.39
ROE
1.46%
ROCE
2.94%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 677.64 Cr | 851.40 Cr | 719.80 Cr | 652.65 Cr |
| Net Profit | -57.88 Cr | 21.74 Cr | -12.97 Cr | 65.27 Cr |
| EPS | -3.69 | 1.39 | -0.83 | 4.16 |
| Operating Profit | -12.44 Cr | 90.58 Cr | 35.35 Cr | 72.87 Cr |
Shareholding pattern
Promoter
59.32%
Public
40.68%
Mutual fund holdings
₹39.54
Cr total
3
Schemes
2
Fund Houses
₹39.54 Cr
Total Exposure
HSBC Mutual Fund₹39.50 Cr (99.9%)
Motilal Oswal Mutual Fund₹0.03 Cr (0.1%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2019 | Dividend | Dividend - Rs 0.20 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.